Sumatriptan Succinate
NDC Package 16590-300-09

11-digit billing NDC: 16590030009

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Sumatriptan Succinate is iNDICATIONS AND USAGESumatriptan Succinate Tablets are indicated for the acute treatment of migraine attacks with or without aura in adults.Sumatriptan Succinate Tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Marketed by Stat Rx Usa, this product is identified by NDC 16590-300 and is authorized under FDA application NDA020132.

Identification & Billing

NDC Package Code
16590-300-09
Package Description
9 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
11-Digit Billing Format
16590030009
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sumatriptan Succinate
Dosage Form
-
Usage Information
INDICATIONS AND USAGESumatriptan Succinate Tablets are indicated for the acute treatment of migraine attacks with or without aura in adults.Sumatriptan Succinate Tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of Sumatriptan Succinate Tablets have not been established for cluster headache, which is present in an older, predominantly male population.

Regulatory & Marketing

Labeler Name
Stat Rx Usa
FDA Application #
NDA020132
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-01-2008
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 16590-300-09 identifies a specific commercial package of 9 tablet, film coated in 1 blister pack of Sumatriptan Succinate, labeled by Stat Rx Usa. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stat Rx Usa on July 01, 2008. The current certification is valid through December 31, 2017.

How is this Stat Rx Usa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 16590030009. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
16590-300-09
11-Digit CMS (5-4-2)
16590-0300-09

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.